Activity of posaconazole against Pseudallescheria boydii: In vitro and in vivo assays

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 4, 2003, Pages 1436-1438

  González, Gloria M ^a,c   Tijerina, Rolando ^c   Najvar, Laura K ^a   Bocanegra, Rosie ^a   Rinaldi, Michael G ^a,b   Loebenberg, David ^d   Graybill, John R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^c Medicina UANL   (Mexico)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; POSACONAZOLE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCOMYCETES; ASPERGILLOSIS; BACTERIAL INFECTION; BACTERIUM ISOLATION; BRAIN HOMOGENATE; COLONY FORMATION; CONTROLLED STUDY; DRUG ACTIVITY; MICROBIOLOGICAL EXAMINATION; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SURVIVAL;

ANIMALS; ANTIBIOTICS, ANTIFUNGAL; DRUG RESISTANCE, FUNGAL; MADUROMYCOSIS; MICE; MICE, INBRED ICR; MICROBIAL SENSITIVITY TESTS; PSEUDALLESCHERIA; TRIAZOLES;

EID: 0037378777     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.4.1436-1438.2003     Document Type: Article

References (14)

1. Braddley, J. W., T. P. Stroud, D. Salzman, and P. G. Pappas. 2001. Invasive mold infections in allogenic bone marrow transplant recipients. Clin. Infect. Dis. 32:1319-1324.
2. Galgiani, J. N., D. A. Stevens, J. R. Graybill, D. L. Stevens, A. J. Tillinghast, and H. B. Levine. 1984. Pseudallescheria boydii infections treated with ketoconazole. Chest 86:219-224.
3. Ginter, G., B. Petutschnig, G. Pierer, H. P. Soyer, S. Reischle, T. Kern, and S. de Hoog. 1998. Atypical cutaneous pseudallescheriosis refractory to antifungal agents. Mycoses 42:507-511.
4. Goldberg, S. L., D. J. Geha, W. F. Marshall, D. J. Inwards, and H. C. Hoagland. 1993. Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazole. Clin. Infect. Dis. 16:803-805.
5. González, G. M., R. Tijerina, L. Najvar, M. Rinaldi, I.-T. Yeh, and J. R. Graybill. 2002. Experimental murine model of disseminated Pseudallescheria infection. Med. Mycol. 40:243-248.
6. Kirkpatrick, W. R., R. K. McAtee, A. W. Fothergill, D. Loebenberg, M. Rinaldi, and T. F. Patterson. 2000. Efficacy of SCH56592 in a rabbit model of invasive aspergillosis. Antimicrob. Agents Chemother. 44:780-782.
7. Lutwick, L. I., J. N. Galgiani, R. H. Johnson, and D. A. Stevens. 1976. Visceral fungal infections due to Petriellidium boydii (Allescheria boydii). Am. J. Med. 61:632-639.
8. Muñoz, P., M. Marín, P. Tornero, P. M. Rabadán, M. Rodríguez-Creixéms, and E. Bouza. 2000. Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy. Clin. Infect. Dis. 31:1499-1501.
9. National Committee for Clinical Laboratory Standards. 1998. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Proposed standard. NCCLS document M38-P. National Committee for Clinical Laboratory Standards, Wayne, Pa.
10. Patterson, T. F., V. T. Andriole, M. J. Zervos, D. Therasse, and C. A. Kauffman. 1990. The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection. Mycoses 33:297-302.
11. Perfect, J. R., G. M. Cox, R. K. Dodge, and W. A. Schell. 1996. In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans. Antimicrob. Agents Chemother. 40:1910-1913.
12. Pfaller, M. A., S. Messer, and R. N. Jones. 1997. Activity of new triazole Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 41:233-235.
13. Singh, N. 2000. Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy. Clin. Infect. Dis. 31:545-553.
14. Travis, L. B., G. D. Roberts, and W. R. Wilson. 1985. Clinical significance of Pseudallescheria boydii: a review of 10 years' experience. Mayo Clin. Proc. 60:531-537.